CDK2 and neoplasm: On the other hand, it can reduce the expression of cell cycle proteins such as Cyclins B1, Cyclins D1, CDK1, CDK2, and CDK4, preventing the transition of tumor cells from the G2 phase to the M phase and inhibiting cell proliferation.